Tarsons Products Reports Strong Financial Growth Amid Rising Interest Expenses in March 2025

Tarsons Products, a small-cap player in the healthcare services industry, has recently reported its financial results for the quarter ending March 2025. The results indicate a notable shift in the company's evaluation, with a revision in its score reflecting a positive trajectory over the past three months.
Key highlights from the financial performance include an impressive operating profit to interest ratio, which reached its highest level in five quarters at 7.12 times, suggesting an enhanced capacity to manage interest obligations. Additionally, profit before tax (PBT) showed significant growth, recorded at Rs 11.79 crore, marking a 53.6% increase compared to the average of the previous four quarters. This trend is mirrored in net sales, which peaked at Rs 112.69 crore, and operating profit (PBDIT), which also reached a five-quarter high of Rs 37.02 crore. The operating profit margin improved to 32.85%, indicating better efficiency in operations. Furthermore, profit after tax (PAT) increased to Rs 10.20 crore, reflecting a growth of 36.5% over the previous four-quarter average.

However, it is important to note that interest expenses have risen to Rs 13.33 crore over the nine-month period, indicating a potential concern regarding increased borrowings.

For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.